Abstract: P-selectin (CD62P) is a member of the selectin family of cell adhesion molecules. It is expressed on stimulated endothelial cells and activated platelets and mediates leukocyte rolling on stimulated endothelial cells and heterotypic aggregation of activated platelets onto leukocytes. It also mediates heterotypic aggregation of activated platelets to cancer cells and adhesion of cancer cells to stimulated endothelial cells. Using P-selectin knockout mice, the importance of P-selectin-mediated cell adhesive interactions in the pathogeneses of inflammation, thrombosis, growth and metastasis of cancers has been clearly demonstrated. Here we will summarize the current knowledge and highlight the important progress in the biomedical research of P-selectin biology, providing a suitable target for therapeutic interventions developed through both experimental and bioinformatic approaches.
INTRODUCTION
The cell-cell interaction is a hallmark of living organisms. It plays central roles in primate development, such as fertilization, implantation, placental formation, embryogenesis, tissue and organ formations [1] . It is also essential for a variety of physiological and pathological processes, including host defense, leukocyte trafficking and recruitment, hemostasis and thrombosis, wound healing, angiogenesis and growth and metastasis of cancer. This interaction is precisely regulated by temporal and spatial expression and display of cell adhesion molecules, cytokines, chemokines and chemotactic factors, proteases, cytoskeletal proteins and extracellular matrix coordinated by various signaling molecules [2, 3] .
The recruitment of leukocytes to the site of bacterial and viral infection is integral to innate immunity. The recruited leukocytes are known to engulf (phagocytosis), kill (microbicidal activity by releasing superoxide, hydrogen peroxide and hydroxyl radical) and digest (releasing several proteases such as myeloperoxidase, elastase and lysozyme, and glycosidases including N-acetyl-β-glucosaminidase and β-glucuronidase) various bacterial and viral pathogens. It is generally believed that leukocytes are indispensable for host defense [1] [2] [3] .
*Address correspondence to this author at the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, University of Minnesota Medical School, Minneapolis, MN 55455, USA; E-mail: gengx001@umn.edu However, the recruited leukocytes can also function as a "double-edged sword" [4] [5] [6] [7] [8] [9] [10] . For example, leukocytes recruited to the site of tissue injury, under certain pathological conditions, can cause further tissue damages to one's self, leading to deepening, broadening and worsening of tissue injury up to irreversible tissue necrosis and complete loss of functionality in a variety of disorders, such as ischemia and reperfusion injury (stroke, myocardial ischemia and infarction, and disseminated intravascular coagulation), shock, systemic septicemia, transplantation, severe trauma and burns, acute lung injury (adult respiratory distress syndrome), and several autoimmune disorders (systemic lupus erythematosus, multiple sclerosis and rheumatoid arthritis, etc.).
SELECTIN FAMILY OF CELL ADHESION MOLECULES
The recruitment of leukocytes from the flowing blood stream across the endothelial cell monolayer of capillary venules into the site of infection or injury requires at least three steps, in which the kinetics of leukocyte emigration and accumulation are precisely regulated [11] . At least five families of cell adhesion molecules participate in leukocyte trafficking, platelet aggregation, cancer growth and metastasis. They are selectins and their cognate glycoprotein ligands, integrins, immunoglobulin (Ig) superfamily of cell adhesion molecules, and cadherins (mediate a homotypic interaction). Selectins react with their glycoprotein ligands, including mucin-like and non-mucin-like molecules for tethering (initial attachment), rolling and weak adhesion of leukocytes. Consequently, integrins react with Ig superfamily of cell adhesion molecules for firm adhesion and signal transduction, which eventually triggers diapedesis and transendothelial migration of leukocytes. The emigrated leukocytes are then guided by several large families of soluble chemoattractants to migrate to their destinations where the insult occurs. It is generally believed that the selectin family of cell adhesion molecules mediates the first step of cell-cell interactions during the recruitment of leukocytes [12] [13] [14] . Fig. (3) . The backbone overlay of lectin domains of P-selectin (red) , L-selectin (green), and E-selectin (blue); reproduced from K.C. Chou [21] with permission. It can be seen that the backbone conformations of the three structures follow almost an identical track from residues 77 to 93 (at the top), but suddenly diverge dramatically from residues 94 to 103 (in the loop between β-strands 3 and 4). This presents a dual feature for the folding of the 77-107 sequence, around which the putative binding sites for ligands are located. Such a unique feature of convergence-divergence duality around the binding site may be of immediate use for rationally designing selectin inhibitors with a given specificity and possible antiadhesion drugs [21] .
The selectin (CD62) family of cell adhesion molecules comprises a unique subfamily of Ca 2+ -dependent animal lectins (C-type lectin) that mediate specific adhesive interactions among leukocytes, platelets and vascular endothelial cells (Fig. 1) . It includes L-selectin (CD62L), a constitutively expressed lymphocyte homing receptor in most leukocytes for high endothelial venules of lymphatic tissues and organs and for leukocytes; E-selectin (CD62E), a transient cytokine-inducible cell surface molecule of endothelial cells for neutrophils, monocytes, memory T lymphocytes, eosinophils and basophils; and P-selectin (CD62P), expressed on the plasma membrane of endothelial cells and platelets following cellular activation and degranulation (exocytosis) as a rapidly inducible receptor for neutrophils, monocytes, T lymphocyte subsets, eosinophils and basophils [15] [16] [17] .
The endothelial P-selectin and E-selectin are thought to be essential for leukocytes tethering to, and rolling on, the monolayer of activated vascular endothelial cells (Fig. 2) . The tethering and rolling mediated by endothelial P-and Eselectins bring leukocytes into proximity with various cytokines, chemokines and chemotactic factors, which collectively activate leukocyte β 2 -integrins to bind to immunoglobulin superfamily of cell adhesion molecules for adhesive arrest. The coordinated interplay of these molecules initiates signal transduction, which triggers diapedesis and transmigration of leukocytes through the endothelial monolayer of the post-capillary venules.
Analogously, the leukocyte L-selectin is critical for the interaction of lymphocytes with the high endothelial venules of lymph nodes and spleens and for the interaction between leukocytes. The adhesive interaction mediated by leukocyte L-selectin directs the homing of lymphocytes to the lymphatic organs. In addition, it triggers adhesion of flowing leukocytes to the adherent leukocytes on the activated endothelial cells, thus amplifying and exaggerating inflammatory reactions [11] [12] [13] [14] [15] [16] [17] .
THE STRUCTURE OF P-SELECTIN
The human P-selectin gene spans over 50 kilobase pairs in chromosome 1. It contains 17 exons, almost all of which encode distinctive domain structures [18, 19] . P-selectin has both membrane and soluble forms in platelets and endothelial cells [19] . The membrane form of P-selectin is a single polypeptide chain of 789 amino acid residues. It is structurally organized into a NH 2 -terminal domain of ~120 residues homologous to Ca 2+ -dependent animal lectin (Ctype lectin or carbohydrate-recognition domain; Fig. 3 ) Fig. (4) . The domain structure of PSGL-1.
followed by an epidermal growth factor-like domain, nine (or eight) complement regulatory protein-like repeats, a transmembrane domain and a cytoplasmic tail [20] [21] [22] . The complement regulatory protein-like repeats, also called complement control protein (CCP) modules, or short consensus repeat (SCR) exist in a wide variety of complement and adhesion proteins, principally the selectins. Although the function of CCP domains is not quite clear, the computer-modeled 3-dimensional structure of CCP is available [23] that may be of use for understanding how these repeat units contribute to so many systems of biological importance. The membrane form of platelet Pselectin is ~140 kDa under reducing conditions and ~120 kDa under non-reducing conditions. It contains 28.8% carbohydrates by weight [24] . The soluble form of P-selectin is derived from an alternative splicing of mRNA, which lacks the exon 14 and therefore results in a deletion of 40 amino acids including the entire transmembrane domain [19] .
Both the membrane and soluble forms of P-selectin bind to leukocytes. Thus, the membrane form of P-selectin expressed on the stimulated endothelial cells and the activated platelets functions as a cell adhesion molecule, mediating the leukocyte binding to endothelial cells and the platelet rosetting on leukocytes/cancer cells [24] [25] [26] [27] . In contrast, the soluble form of P-selectin in circulation (~100 ng/ml) acts competitively as an anti-adhesion molecule. Under certain pathological conditions characterized by microcirculation disorders, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome and adult respiratory distress syndrome, the plasma concentrations of soluble P-selectin may be increased to as high as 1 µg/ml [28, 29] . Therefore, it is conceivable that the membrane and soluble forms of P-selectin may work coordinately in vivo for the regulation of their cell adhesion functionality.
The recombinant soluble P-selectin, prepared by the deletion of the transmembrane domain and the cytoplasmic domain, is a monomeric rod-like structure (~38 nm) with the globular domain (~4 nm) at one end. The membrane Pselectin, isolated from human platelets, exists as dimeric and oligomeric forms even at the detergent concentrations well above the critical micelle concentration. Without added detergents, the membrane P-selectin appears as rosettes of 2-6 molecules with the NH 2 -terminal globular domains projecting out and the COOH-terminal domains in contact at the center of the rosettes, as revealed by rotary shadowing electron microscopy [30] . The dimerization and/or oligomerization of P-selectin are thought to be critical for providing the avidity of P-selectin mediated cell adherent events under shear stress of the post-capillary venules [30, 31] and for cross-linking of PSGL-1 (P-selectin glycoprotein ligand-1, CD162) that activates mitogen-activated protein kinases in the downstream of signaling pathways [32, 33] .
THE ROLES OF P-SELECTIN IN HOST DEFENSE AND INFLAMMATION
P-selectin is normally stored in the α -granules of platelets and the Weibel-Palade bodies of endothelial cells. Upon thrombogenic and inflammatory challenges, P-selectin is rapidly expressed, by exocytosis, on the cell surfaces of activated platelets and stimulated endothelial cells [11] [12] [13] [14] [15] [16] [17] . It binds to a disulfide bond-linked homodimeric sialomucin, called PSGL-1 (Fig. 4) [34] . PSGL-1 is expressed on the cell surface of most leukocytes, such as neutrophils, monocytes and certain subsets of T lymphocytes including Th1 cells, eosinophils and basophils. The binding of Pselectin to leukocytes requires sialylated and fucosylated carbohydrate structures (a lectin/carbohydrate pair); their prototype is Siaα2-3Galβ1-4(Fucα1-3)GlcNAc, called sialyl Lewis x (SLe x ) [11] [12] [13] [14] [15] [16] [17] . The existence of SLe x -like moieties on O-linked glycans of PSGL-1 further supports this notion [34] [35] [36] . P-selectin interacts with PSGL-1 to mediate rolling of leukocytes on the stimulated endothelial cells and heterotypic aggregation of the activated platelets on leukocytes (Fig. 2) . P-selectin knockout mice are defective in leukocyte rolling, extravasation, and hemostasis [37, 38] and PSGL-1 knockout mice manifest impaired rolling and migration of leukocytes [39] [40] [41] , attesting to the in vivo functional importance of this receptor/ligand pair of cell adhesion molecules.
THE ROLES OF P-SELECTIN IN HEMOSTASIS AND THROMBOSIS
Although the physiological and pathological roles of platelet P-selectin in haemostasis and thrombosis are less understood and appreciated, the functional significance of platelet P-selectin, especially its roles in the platelet/leukocyte interaction, has recently begun to emerge from the insightful animal and clinical observations [42] .
Using an in vivo model of experimental thrombosis, Pselectin, expressed on activated platelets, appears to recruit a sufficient amount of circulating leukocytes, including monocytes, to the growing thrombi [43] . This pathological event can up-regulate the expression of tissue factor (TF) on the monocytes in situ [44] and facilitate the transfer of TFcontaining microparticles that contain PSGL-1, leading to significantly more deposition of fibrin within the thrombi [45] . Along this line of investigation, defective hemostasis featured by a 40% prolongation of bleeding time and a twofold increase in hemorrhage is observed in P-selectin knockout mice [38] . Overexpression of soluble P-selectin corrects hemostasis in a mouse model of hemophilia A [46] . Blocking of P-selectin by P-selectin monoclonal antibodies can accelerate the streptakinase induced pharmacological thrombolysis [47] and decrease the formation of venous thrombosis [48] . Clinically, patients with stable coronary artery disease have increased platelet reactivity characterized by P-selectin expression and circulating monocyte-platelet aggregates mediated by P-selectin [49] .
Resting and activated platelets have been shown to roll on endothelial P-selectin in vivo, indicating a ligand activity for P-selectin on platelets [50, 51] . Recently, P-selectin has been reported to react with platelet glycoprotein Ibα in the platelet glycoprotein Ib-IX-V complex [52] , PSGL-1 expressed on platelets [53] and a 28-kDa glycoprotein isolated by P-selectin affinity chromatography [54] . Furthermore, P-selectin, expressed on the activated platelets, has been found to have a prominent role in stabilization of platelet aggregates and in size determination of platelet aggregates [55] [56] [57] . These results demonstrate that P-selectin plays an important role in hemostasis and thrombosis by mediating the heterotypic aggregation of platelets on stimulated endothelial cells and on adherent leukocytes, the homotypic aggregation of activated platelets, and the transfer of microparticles containing both TF and PSGL-1.
THE ROLES OF P-SELECTIN IN CANCER GROWTH AND METASTASIS
Metastasis is a cascade of cellular events by which cancer cells establish new colonies at distant sites in the body [58, 59] . It comprises multiple and consecutive steps. Several cell adhesion molecules are involved in the various stages of cancer metastasis [60] . P-selectin has been shown to bind to several human cancers and human cancer-derived cell lines, such as colon cancer, lung cancer including small cell lung cancer, breast cancer, malignant melanoma, gastric cancer, neuroblastoma and adenoid cystic carcinoma of the salivary gland [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] . There is an increasing body of in vivo experimental evidence, indicating that P-selectin can play important roles in this process. Recently, using P-selectin deficient mice, it has been clearly demonstrated that adhesion of cancer cells mediated by P-selectin plays an important role in the growth and metastasis of human colon carcinoma in vivo [72] .
The ligand molecules on cancer cells for P-selectin remain elusive. Several lines of evidence suggest that the binding of human cancer cells, derived from various organs and/or tissues, to P-selectin, may be mediated by very different (cell-type specific?) glycoprotein ligands. First, HL-60 cells, a cell line of human promyeloid origin, express PSGL-1. This molecule is a cysteine-linked homodimeric molecule with apparent molecular masses of ~120 kDa under reducing conditions and ~240 kDa under non-reducing conditions [34] . Second, NKI-4 cells, a human malignant melanoma cell line, express three potential glycoproteins as ligands for P-selectin. These molecules have apparent molecular masses of ~250, ~110 and ~100 kDa under reducing conditions and ~230, ~105 and ~85 kDa under nonreducing conditions [68] . Third, NCI-H345 cells, a cell line of human small cell lung cancer, express two P-selectin binding glycoproteins, with apparent molecular masses of 220 kDa and ~110 kDa under both reducing and nonreducing conditions [70] . Finally, Acc-M cells, a cell line derived from a human adenoid cystic carcinoma of a salivary gland, express the ~160-, ~54-, and ~36-kDa molecules, recognized by P-selectin, from the cell surface of Acc-M cells [71] . In this regard, the elucidation of the molecular mechanisms responsible for regulation of the expression of these different P-selectin ligand molecules, in various human cancer cells, will be an important and very interesting future task.
Although selectins bind to sialylated and fucosylated carbohydrates, such as sialyl Lewis x (SLe x ) and its derivatives, as their minimal recognition motif [11] [12] [13] [14] [15] [16] [17] , Pand L-selectins, but not E-selectin also bind to heparin and heparan sulfates, which inhibit leukocyte adhesion mediated by P-and L-selectin, but not leukocyte adhesion mediated by E-selectin [61, [73] [74] [75] [76] [77] [78] . In addition, heparan sulfate-like proteoglycans present on certain types of non-blood borne, "∞epithelial-like" human cancer cells can directly mediate their adhesion to P-selectin [69] . Consistent with the essential role of tyrosine sulfation for the interaction of Pselectin with PSGL-1, sulfation is also critically required for P-selectin binding to somatic cancer cells [71] .
It should be mentioned that the moderate binding affinity, the fast on rate (k on ) and the fast off rate (k off ) are Fig. (5) . The signaling molecules and their pathways involved in P-selectin exocytosis in platelets.
known to be the three fundamental biophysical elements for leukocyte rolling on selectins under shear stress [79] [80] [81] [82] . For example, as measured by the technique of surface plasmon resonance, the interaction of P-selectin with PSGL-1 has a K d value of 320 ± 20 nM, a k off value of 1.4 ± 0.1 s -1 and a k on value of 4.4 × 10 6 M -1 s -1 [81] . Notably, although human neutrophils and promyeloid HL-60 cells can roll on and adhered to P-selectin (a P-selectin/PSGL-1 pair), cancer cells can only adhered to, but not roll on, P-selectin (a Pselectin/heparin pair) under flow [67, 69, 71] . Interestingly, the affinity and kinetics of P-selectin binding to heparin has a K d value of 115 ± 6 nM, a k off value of 3.15 ± 0.34 × 10 -3 s -1 and a k on value of 2.75 × 10 4 M -1 s -1 [83] . Given the similar binding affinities for the P-selectin/PSGL-1 and Pselectin/heparin interactions, it is apparent that the slow k off (a ~1,000-fold increase) and the reduced k on (a ~100-fold reduction) are the key determinators for rolling (fast k off and k on ) of leukocytes (a P-selectin/PSGL-1 pair) versus adhesion (slow k off and k o n ) of cancer cells (a Pselectin/heparin pair) under flow.
REGULATION OF P-SELECTIN EXOCYTOSIS
The expression of P-selectin is regulated at both the transcriptional and cellular levels. At the transcriptional level, tumor necrosis factor-α induces P-selectin expression in mouse and bovine endothelial cells [84, 85] while interleukin-4 and oncostatin M induces P-selectin expression in human umbilical vein endothelial cells, which can last up to 72 hours [86] . At the cellular level, P-selectin is stored in the α-granules of platelets and the Weibel-Palade bodies of endothelial cells. Upon thrombogenic and inflammatory challenges, P-selectin is rapidly expressed, by exocytosis, on activated platelets and stimulated endothelial cells [11] [12] [13] [14] [15] [16] [17] . However, the molecular mechanisms governing the regulation of the rapid mobilization of P-selectin in these cells remain largely elusive.
Over the years, various specific inhibitors have been studied for their abilities to inhibit P-selectin exocytosis (Fig. 5 ) . For instance, Gö6976 and UCN-01 (7-hydroxystaurosporine; inhibitors for protein kinase C) have been shown to abolish the exocytotic expression of Pselectin in both activated platelets and stimulated endothelial cells [87, 88] . KT5823 (an inhibitor of protein kinase G) can attenuate P-selectin exocytosis on stimulated endothelial cells [89] . Sphingosine derivatives, such as N,Ndimethysphingosine and N,N,N-trimethylsphingosine, can block the exocytosis of P-selectin on activated platelets [90] . Wortamannin and LY294002 (inhibitors of phosphatidylinositol kinases) can abrogate the secretion of α-granules in platelets [91] [92] [93] . Phenylarsine oxide and diamide (inhibitors of protein tyrosine phosphatases) can suppress P-selectin expression in α-thrombin or phorbol myristate acetate activated human platelets and can abolish the P-selectin mediated aggregation of activated platelets to neutrophils [93, 94] . Consistent with the general scheme of protein phosphorylation involvement in P-selectin exocytosis, treatment of platelets from mev/mev mice (containing a mutation within the shp-1 gene that results in nearly complete loss of its catalytic activity) with collagen and collagen-related peptide manifests hypophosphorylation of Syk and Lyn, and reduced P-selectin expression [89] .
The SNARE (soluble NSF attachment protein receptor) mechanism for vesicle trafficking of proteins also participates in the regulation of P-selectin exocytosis. The SNARE complex contains three components: t-SNAREs, vSNAREs, and a soluble SNAP/NSF. The t-SNAREs, such as the syntaxins and SNAP-25, are target receptors found on the targeting membrane. The v-SNAREs are vesicleassociated membrane proteins (VAMP or synaptobrevins). The soluble components consist of NSF (N-ethylmaleimidesensitive factor) and soluble NSF-attachment proteins (SNAPs; a, b, g isoforms). Platelets, like neurons and other cells capable of regulated secretion, contain a full set of interacting proteins-VAMP, SNAP-25, and syntaxin 4-that are necessary for vesicle docking and fusion with the plasma membrane. Platelets also have PSP (platelet Sec1 protein), a putative regulator of vesicle docking, which regulates the formation of the SNARE complex through binding to syntaxin 4 [95] . Peptides that mimic NSF sequence motifs can inhibit the secretion of both α-granules and densegranules in permeabilized human platelets [96] while VAMP and Syntaxin 4 antibodies can interfere with the exocytosis of α-granules [97] . In addition, Rab4, a member of a large family of Ras-related low molecular weight GTPases essential for vesicle trafficking and fusion, appears to regulate the exocytosis of α-granules, but not dense granules [98] . 
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